Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Oneview Healthcare PLC (ONVVF)
Dublin, IE
Oneview Healthcare PLC, headquartered in Dublin, Ireland since its establishment in 2008, specializes in furnishing bespoke software and expert consulting services. These offerings are tailored for the global healthcare industry, with a presence spanning Ireland, the United States, Australia, Asia, and the Middle East. The company's core offerings revolve around its Care Experience Platform (CXP), which includes several distinct solutions: CXP Cloud Start: Designed to enable clients to seamlessly deploy essential digital engagement functionalities across their entire organizational footprint. CXP Cloud Enterprise: This solution empowers patients and their relatives to communicate virtually with healthcare providers, while also providing access to vital educational resources and health-related information. CXP Enterprise On-Prem: A robust on-premise offering engineered to address diverse institutional requirements, suitable for a wide range of facilities, from new construction projects to existing hospitals utilizing legacy infrastructure. Furthermore, Oneview Healthcare also provides specialized tools aimed at enhancing patient and family empowerment, optimizing the overall patient experience, facilitating remote virtual care delivery, and offering solutions like digital room signage and interactive patient communication boards.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +14.29% | +400.00% | +400.00% | +400.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Medical - Healthcare Information Services: +14.2%+20.6% ★ Q4'25: +38.0% (vs Q4'23)
-
EPS growth Medical - Healthcare Information Services: +43.1%-77.2% Q4'25: -148.0% (vs Q4'23)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%-102.3% Q4'25: -66.2% (vs Q4'23)
-
EBIT margin Medical - Healthcare Information Services: +8.8%-92.1% Q4'25: -82.8% (vs Q4'23)
-
ROIC Medical - Healthcare Information Services: +5.2%-1,065.5% Q4'25: -1,838.1% (vs Q4'23)
-
Share dilution Medical - Healthcare Information Services: -0.1%-35.0% ★ Q4'25: -47.5% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×-0.19× Q4'25: -0.11× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
8.99M
est: 9.60M (-6.4%)
|
5.76M
est: 7.92M (-27.2%)
|
8.20M
est: 18.17M (-54.9%)
|
7.10M
est: 5.05M (+40.5%)
|
7.10M
est: 25.26M (-71.9%)
|
9.73M
est: 31.45M (-69.1%)
|
8.92M
est: 9.63M (-7.4%)
|
9.40M
est: 10.37M (-9.4%)
|
9.89M
est: 9.71M (+1.9%)
|
11.93M
est: 12.55M (-4.9%)
|
14.82M
14.68M – 14.97M
+18.2% YoY
|
20.08M
19.83M – 20.33M
+35.5% YoY
|
26.67M
26.37M – 26.98M
+32.8% YoY
|
36.39M
35.98M – 36.81M
+36.4% YoY
|
| EBITDA |
-22.96M
est: -8.95M (-156.6%)
|
-23.34M
est: -7.38M (-216.2%)
|
-19.44M
est: -16.94M (-14.7%)
|
-15.73M
est: -4.71M (-234.0%)
|
-7.44M
est: -23.56M (+68.4%)
|
-8.01M
est: -29.32M (+72.7%)
|
-12.09M
est: -8.98M (-34.7%)
|
-7.88M
est: -9.67M (+18.5%)
|
-10.10M
est: -8.82M (-14.5%)
|
-10.48M
est: -11.39M (+8.0%)
|
-13.46M
-13.60M – -13.33M
-18.2% YoY
|
-18.23M
-18.46M – -18.01M
-35.5% YoY
|
-24.22M
-24.50M – -23.95M
-32.8% YoY
|
-33.05M
-33.42M – -32.67M
-36.4% YoY
|
| EBIT |
-15.98M
est: -9.07M (-76.1%)
|
-24.07M
est: -7.48M (-221.6%)
|
-20.20M
est: -17.17M (-17.6%)
|
-16.82M
est: -4.77M (-252.3%)
|
-7.60M
est: -23.88M (+68.2%)
|
-8.10M
est: -29.72M (+72.7%)
|
-12.19M
est: -9.10M (-33.9%)
|
-8.37M
est: -9.80M (+14.6%)
|
-10.62M
est: -9.02M (-17.7%)
|
-10.99M
est: -11.66M (+5.8%)
|
-13.78M
-13.92M – -13.64M
-18.2% YoY
|
-18.66M
-18.89M – -18.43M
-35.5% YoY
|
-24.79M
-25.07M – -24.51M
-32.8% YoY
|
-33.82M
-34.21M – -33.44M
-36.4% YoY
|
| Net Income |
-16.03M
est: -284.06M (+94.4%)
|
-25.90M
est: -436.79M (+94.1%)
|
-20.28M
est: -317.12M (+93.6%)
|
-16.94M
est: -203.03M (+91.7%)
|
-9.45M
est: -136.06M (+93.1%)
|
-8.19M
est: -80.34M (+89.8%)
|
-10.87M
est: -21.08M (+48.4%)
|
-8.93M
est: -23.62M (+62.2%)
|
-10.84M
est: -11.97M (+9.5%)
|
-12.51M
est: -11.47M (-9.1%)
|
-7.59M
-7.70M – -7.47M
+33.9% YoY
|
-4.17M
-4.23M – -4.11M
+45.0% YoY
|
379.3K
373.7K – 384.9K
+109.1% YoY
|
6.07M
5.98M – 6.16M
+1,500.0% YoY
|
| SGA |
11.80M
est: 6.78M (+74.0%)
|
13.82M
est: 5.59M (+147.1%)
|
11.81M
est: 12.84M (-8.0%)
|
9.00M
est: 3.57M (+152.2%)
|
4.99M
est: 17.85M (-72.0%)
|
5.58M
est: 22.21M (-74.9%)
|
7.46M
est: 6.80M (+9.7%)
|
6.20M
est: 7.33M (-15.4%)
|
7.52M
est: 6.61M (+13.6%)
|
6.89M
est: 8.55M (-19.4%)
|
10.10M
10.00M – 10.20M
+18.2% YoY
|
13.68M
13.51M – 13.85M
+35.5% YoY
|
18.17M
17.97M – 18.38M
+32.8% YoY
|
24.79M
24.51M – 25.07M
+36.4% YoY
|
| EPS |
-0.17
est: -0.24 (+31.6%)
|
-0.24
est: -0.37 (+36.7%)
|
-0.15
est: -0.27 (+46.2%)
|
-0.06
est: -0.17 (+65.2%)
|
-0.03
est: -0.12 (+78.0%)
|
-0.01
est: -0.07 (+86.1%)
|
-0.01
est: -0.02 (+41.9%)
|
-0.01
est: -0.02 (+38.7%)
|
-0.01
est: -0.02 (+41.2%)
|
-0.02
est: -0.01 (-8.7%)
|
-0.01
-0.01 – -0.01
+33.9% YoY
|
-0.01
-0.01 – -0.01
+45.0% YoY
|
0.00
0.00 – 0.00
+109.1% YoY
|
0.01
0.01 – 0.01
+1,500.0% YoY
|
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| James Fitter | Chief Executive Officer & Executive Director | 722.6K | male |
| Darragh Fergal Lyons | Chief Financial Officer & Executive Director | 331.1K | male |
| Howe | Chief Operations Officer | — | male |
| Niall O'Neill | Chief Product Officer | — | male |
| Richard Eibrand | Head of Information Security and IT Operations | — | male |
| Toni Pettit | Chief of Staff & Company Secretary | — | female |
| Aoife Meehan | Human Resources Director | — | female |
| William Hadden | Managing Director of ANZ | — | male |
| Declan Bright | Chief Technology Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ONVVF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
